Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABAP: Post-op Antibiotics in Complicated Appendicitis
NCT03688295Phase 3Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Feb 2019
- Primary completion
- Sep 2025
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ceftriaxone and metronidazole in acute appendicitis, sponsored by CHU Amiens-Picardie. Primary endpoint: Proportion of patients having developed organ space surgical site infections at 30 days. Started Feb 2019; status: recruiting.
02
Drugs
ceftriaxonemetronidazole
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on NCT03688295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03688295.